January 24, 2025 press release from the U.S. Department of Justice.
Pfizer has agreed to pay nearly $60 million to settle allegations that its subsidiary, Biohaven, engaged in illegal kickback schemes before Pfizer acquired the company.
The DOJ alleged that Biohaven violated anti-kickback laws by providing financial incentives for prescribing the migraine drug Nurtec ODT.
“The department will use every tool at its disposal to prevent pharmaceutical manufacturers from undermining the objectivity of treatment decisions by health care providers.”
Let's start with the truth!
Support the Broken Science Initiative.
Subscribe today →
recent posts
Inside Dave Feldman’s KetoCa study and the questions surrounding its data, analysis, and quality control
Paradigm Shifts, Entrenched Thinking, and the Future of Medicine
A new paper proposes a single ratio, read off a fingerprick, that tells you where your metabolism is headed. It started in a cancer clinic. Its authors think it belongs in every MetFix affiliate.
